CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
US Top News and Analysis (RSS)
US Top News and Analysis (RSS)
CNBC
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
Starting July 1, Caremark will prioritize Wegovy on its formulary, making the weekly injection more accessible to its members.
GM lowers 2025 guidance, citing up to $5 billion in tariff exposure
US Top News and Analysis (RSS)
US Top News and Analysis (RSS)
CNBC
GM lowers 2025 guidance, citing up to $5 billion in tariff exposure
GM on Thursday lowered its 2025 earnings guidance to include a possible $4 billion to $5 billion impact as a result of President Donald Trump's auto tariffs.
CVS tops estimates, hikes guidance as insurance business shows some improvement
US Top News and Analysis (RSS)
US Top News and Analysis (RSS)
CNBC
CVS tops estimates, hikes guidance as insurance business shows some improvement
The company now expects full-year adjusted earnings of $6 to $6.20 per share, up from a previous guidance of $5.75 to $6 per share.
Trump rewrites crypto rules in first 100 days, industry celebrates '180 pivot' from Biden years
US Top News and Analysis (RSS)
US Top News and Analysis (RSS)
CNBC
Trump rewrites crypto rules in first 100 days, industry celebrates '180 pivot' from Biden years
President Donald Trump’s first 100 days back in office have ushered in a sweeping pro-crypto shift in Washington.
How wealthy horse owners finance their passion and potentially earn millions
US Top News and Analysis (RSS)
US Top News and Analysis (RSS)
CNBC
How wealthy horse owners finance their passion and potentially earn millions
The Kentucky Derby's first place prize is $3.1 million, but track winnings aren't the most lucrative part of race horse ownership.
Eli Lilly sales soar 45% on weight loss drug demand, but drugmaker cuts profit outlook after cancer treatment deal
US Top News and Analysis (RSS)
US Top News and Analysis (RSS)
CNBC
Eli Lilly sales soar 45% on weight loss drug demand, but drugmaker cuts profit outlook after cancer treatment deal
Eli Lilly said sales of weight loss drug Zepbound and diabetes treatment Mounjaro surged in the first quarter.
Eli Lilly CEO says company can help 'respond' to national security concerns around essential drugs as tariffs loom
US Top News and Analysis (RSS)
US Top News and Analysis (RSS)
CNBC
Eli Lilly CEO says company can help 'respond' to national security concerns around essential drugs as tariffs loom
Ricks said reshoring manufacturing capacity for older essential medicines is "a valid thing," adding that Eli Lilly is "happy to help."
Meta Platforms jumps 6% on earnings beat, advertising resilience
US Top News and Analysis (RSS)
US Top News and Analysis (RSS)
CNBC
Meta Platforms jumps 6% on earnings beat, advertising resilience
Investors this earnings season are watching for signs that President Donald Trump's tariff push and global trade uncertainty are hampering advertising demand.
U.S. Chamber of Commerce asks Trump for tariff exclusions to 'stave off a recession'
US Top News and Analysis (RSS)
US Top News and Analysis (RSS)
CNBC
U.S. Chamber of Commerce asks Trump for tariff exclusions to 'stave off a recession'
President Donald Trump has held up tariffs as a key tool in trade negotiations, but some analysts warn the duties are hurting business and the overall economy.
Weekly jobless claims surge to 241,000, more than expected, in latest sign of economic trouble
US Top News and Analysis (RSS)
US Top News and Analysis (RSS)
CNBC
Weekly jobless claims surge to 241,000, more than expected, in latest sign of economic trouble
Initial unemployment claims posted an unexpected increase last week in a potential trouble sign for the wobbling U.S. economy.
This lesser-known 401(k) feature can kickstart your tax-free retirement savings
US Top News and Analysis (RSS)
US Top News and Analysis (RSS)
CNBC
This lesser-known 401(k) feature can kickstart your tax-free retirement savings
Big savers can use after-tax 401(k) contributions to kickstart tax-free retirement savings. Here's what investors need to know.